Subsequent Events

3 Months Ended

Mar. 31, 2013

Subsequent Events

Subsequent Events

(10) Subsequent Events

On April 12, 2013, the Company, with approval of the Board of Directors and its majority shareholder, filed a Schedule 14C with the SEC announcing the decision to amend the Articles of Incorporation to increase its authorized shares from 490,000,000 to 5,000,000,000 shares and to change the name of the Company to CVSL Inc.  The additional authorized shares available will be necessary to pursue its acquisition strategy in the direct selling industry.  The current name neither reflects our future business plans nor our public relations campaign as the Company is no longer engaged in the medical device business.  The Company has received approval of the amendment from the Secretary of State of Florida (state of incorporation) and Financial Industry Regulatory Authority and the amendment will be effective May 27, 2013.